Life Biosciences — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Life Bioscienceslifebiosciences.comin𝕏Nov 2025SEC filinghigh confidence
Longevity company with diversified therapies to extend healthy human lifespan
Boston, US
David Sinclair(Director)Gerald McLaughlin(Executive Officer, Director)Sharon Rosenzweig-Lipson(Executive Officer)Michael Ringel(Executive Officer)Amit Shashank(Executive Officer)Alexander Tristan Edwards(Executive Officer)
Board seatDavid SinclairAdam NeumannBracken Darrell· per SEC Form D · $31M raise · filed Apr 2026
Co-investorsAlpha Wave GlobalThe Venture CollectiveW ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.